Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections
| Status: | Completed |
|---|---|
| Conditions: | Endocrine |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 8/16/2018 |
| Start Date: | September 2016 |
| End Date: | July 2018 |
In this cross-sectional study the investigators will examine two populations: young adults
with (ages 18-35) and older adults (ages 65 and over) with diabetes who are on > 2 insulin
injections per day. The sample size for this observational study will be up to 125 patients.
The investigators will issue a Common Sensing GoCap bluetooth-enabled pen cap that fits on
the end of Solostar Lantus and Apidra insulin pens; this pen cap registers the position of
the insulin pen plunger and automatically sends confirmation of dose delivery to a smartphone
app.
with (ages 18-35) and older adults (ages 65 and over) with diabetes who are on > 2 insulin
injections per day. The sample size for this observational study will be up to 125 patients.
The investigators will issue a Common Sensing GoCap bluetooth-enabled pen cap that fits on
the end of Solostar Lantus and Apidra insulin pens; this pen cap registers the position of
the insulin pen plunger and automatically sends confirmation of dose delivery to a smartphone
app.
Inclusion Criteria:
- Type 1 diabetes or insulin-requiring Type 2 diabetes
- > 2 insulin injections
- Age 18-35 or older than 65 years
- Use of glargine insulin as basal insulin
- Stable insulin doses for past 3 months
Exclusion Criteria:
- Previous tape/adhesive allergies with CGM sensors
- Visual or cognitive impairment with inability to self-administer insulin
We found this trial at
1
site
Joslin Diabetes Center Joslin Diabetes Center, located in Boston, Massachusetts, is the world's largest diabetes...
Click here to add this to my saved trials
